Despite opposition from many stakeholders, a bipartisan contingent of Congress, and CMS’ own advisory panel,the agency is moving forward with its...Read More »
Thank you to everyone who joined us October 23–24 at the 2017 Revenue Integrity Symposium in Franklin, Tennessee. We enjoyed connecting with...Read More »
The Food and Drug Administration (FDA) approved the first gene therapy released in the U.S., Kymriah, also known as chimeric antigen receptor T-...Read More »
The National Association of Healthcare Revenue Integrity (NAHRI) is a new association dedicated to providing revenue integrity professionals with...Read More »
